Page 577 - Multidisipliner Covid 19
P. 577

COVID-19 Pandemisi ve Kalp-Damar Sistemi


                       acteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020
                       Feb 28. [Epub ahead of print], doi: 10.1056/NEJMoa2002032.
                   81.  Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk
                       factors for mortality of adult inpatients with COVID-19 in Wuhan,
                       China: a retrospective cohort study. Lancet 2020 Mar 28;395:1054–62.
                   82.  Chang JC. TTP-like syndrome: novel concept and molecular pathogen-
                       esis of endotheliopathy-associated vascular microthrombotic disease.
                       Thromb J 2018;16:20.
                   83.  Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of
                       SARS-CoV-2 infection-a review of immune changes in patients with
                       viral pneumonia. Emerg Microbes Infect 2020;9:727–32.
                   84. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboem-
                       bolism in patients with severe novel coronavirus pneumonia.J Thromb
                       Haemost 2020 Apr 9. [Epub ahead of print], doi: 10.1111/jth.14830.
                   85.  Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers
                       DAMPJ, Kant KM, et al. Incidence of thrombotic complications in
                       critically ill ICU patients with COVID-19. Thromb Res 2020 Apr 10.
                       [Epub ahead of print], doi: 10.1016/j.thromres.2020.04.013.
                   86.  Xu J, Wang L, Zhao L, Li F, Liu J, Zhang L, et al. Risk assessment of
                       venous thromboembolism and bleeding in COVID-19 patients. Pulmo-
                       nology 2020 Mar 14. [Epub ahead of print], doi: 10.21203/rs.3.rs-
                       18340/v1.
                   87.  COVID-19 and Coagulopathy: Frequently Asked Questions. Available
                       at: https://www.hematology.org/covid-19/covid-19-and-coagulopathy.
                       2020.Accessed May 5
                   88.  Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjo-
                       la VP, ET AL. 2019 ESC Guidelines for the diagnosis andmanagement
                       of acute pulmonary embolism developed in collaboration with the
                       European Respiratory Society (ERS): The Task Force for the diagnosis
                       and management of acute pulmonary embolism of the European
                       Society of Cardiology (ESC). Eur Respir J.2019;54:1901647.
                   89. Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide
                       RS. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy
                       Series from New Orleans. medRxiv 2020 Apr 10. [Epub ahead of
                       print], doi: 10.1101/2020.04.06.20050575
                   90. Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA,
                       ET AL. Tissue Plasminogen Activator (tPA) Treatment forCOVID-19




                       576
   572   573   574   575   576   577   578   579   580   581   582